Life Biosciences reports first-in-human safety data for ER-100 epigenetic reprogramming therapy
Three glaucoma patients tolerated the low dose with no serious adverse events and the dose will escalate; vision signals in two are preliminary.

Aimed at classification, extraction, routing and coding subagents; available in the Claude API, AWS Bedrock, Google Cloud and Microsoft Foundry.
Three glaucoma patients tolerated the low dose with no serious adverse events and the dose will escalate; vision signals in two are preliminary.
Talks are early; the Alphabet drug-discovery spinoff last raised a $2.1 billion Series B in May. Round size and investors are not disclosed.
The 'mito-polariton' is inferred rather than directly measured; the bioRxiv work is not peer reviewed and needs independent replication.
Capacity comes from uprates at 11 existing reactors, with Constellation investing more than $4.3 billion and the first uprate expected in 2028.
In HER2CLIMB-05, median progression-free survival was 24.9 months versus 16.3 with placebo; overall survival data are immature.

CoreWeave will be sole tenant of three 80 MW buildings running Nvidia Vera Rubin, with phase one targeted for mid-2028.
The model card says it accepts up to 14 reference images and supports Search grounding; it ships in Gemini, AI Studio and the Gemini API.
The startup raised about $10 million led by General Catalyst; AI handles balance and navigation while a specialist controls critical actions.

The deal builds demonstration sites but names no robot model, task list, fleet size or timetable for routine use.
The GitHub release spans 372 problem families with many proofs formalized in Lean; mathematicians are still assessing which results are new.
The arXiv preprint claims deterministic O(n^1.9992) 3SUM for bounded integers, which would refute long-standing hardness conjectures; peer review is pending.